Event-Driven Stocks

Schrodinger, Inc.

SDGRNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$255.9M$207.5M$216.7M$181.0M$137.9M$108.1M
Operating income−$166.9M−$209.3M−$177.4M−$146.8M−$111.4M−$60.9M
Net income−$103.3M−$187.1M$40.7M−$149.2M−$100.4M−$24.5M
Total assets$726.2M$823.2M$803.0M$688.6M$756.5M$746.3M
Total liabilities$362.1M$401.8M$254.4M$240.7M$199.4M$122.2M
Equity$364.1M$421.4M$548.6M$447.9M$557.1M$624.0M
EPS (diluted)$-1.41$-2.57$0.54$-2.10$-1.42$-0.41
Shares out.73.4M72.7M63.0M62.2M61.8M60.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−65.2%
Net margin
−40.4%
Return on equity
−28.4%
Return on assets
−14.2%
Return on capital (ROCE)
−31.1%
Liabilities / assets
49.9%
Debt / equity
0.99×
Book value / share
$4.96
Revenue growth (YoY)
23.3%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-0.33distress
Accruals / assets
−16.1%clean
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
62
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 2 warning● 4 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202610.3M7.0-1.1%
Apr 30, 202610.4M6.2-4.9%
Apr 15, 202610.9M8.9-1.8%
Mar 31, 202611.1M10.9-1.8%
Mar 13, 202611.3M9.5+2.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)